The National Alliance for the Mentally Ill of Michigan and the National Urban Indian Coalition have joined the pharmaceutical industry in a lawsuit aimed at blocking Michigan from implementing a Medicaid formulary that would require additional rebates from manufacturers. The Pharmaceutical Research and Manufacturers of America, which filed the suit against HHS in July, and the new plaintiffs argued their case today in U.S. District Court in Washington, saying the Michigan program violates federal law and prevents patients from receiving effective treatment. The suit requests an injunction prohibiting HHS from approving similar programs as well as an order terminating Michigan's program specifically and other state initiatives with similar "illegal features." The International Patient Advocacy Association and the Florida Drop-In Center Association have jointly filed a friend-of-the-court brief in the case, arguing that Michigan's program and others like it "limit Medicaid patients' access to the newest and most effective medicines." -- Jeff Tieman
PhRMA gains allies in Medicaid formulary suit
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.